APO Research

APO RESEARCH · REPORT

Memantine Hydrochloride Tablets

Selected research

Market Outlook & Growth Opportunities

Global Memantine Hydrochloride Tablets Market Outlook and Growth Opportunities 2026

Market perspective

The global Memantine Hydrochloride Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Memantine Hydrochloride Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Memantine Hydrochloride Tablets market include Teva Pharmaceuticals USA, Sun Pharma, United Laboratories, Upsher-Smith, Taj Pharma India Limited, Sharon Bio-medicine Limited, Psycogen Captab, Kabir Lifesciences and Consern Pharma Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Memantine Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Memantine Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Memantine Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Memantine Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Memantine Hydrochloride Tablets Segment by Company

Teva Pharmaceuticals USA

Sun Pharma

United Laboratories

Upsher-Smith

Taj Pharma India Limited

Sharon Bio-medicine Limited

Psycogen Captab

Kabir Lifesciences

Consern Pharma Limited

Aripolis Biotech Pvt. Ltd.

Ajanta Pharma Ltd.

Actiza Pharmaceutical Pvt. Ltd.

Memantine Hydrochloride Tablets Segment by Type

Immediate-Release Tablets

Extended-Release Tablets

Memantine Hydrochloride Tablets Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Memantine Hydrochloride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Memantine Hydrochloride Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Memantine Hydrochloride Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Memantine Hydrochloride Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Memantine Hydrochloride Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Memantine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine Hydrochloride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Memantine Hydrochloride Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Memantine Hydrochloride Tablets industry.

Chapter 3: Detailed analysis of Memantine Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Memantine Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Memantine Hydrochloride Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Memantine Hydrochloride Tablets Industry Trends Table 2. Memantine Hydrochloride Tablets Industry Drivers Table 3. Memantine Hydrochloride Tablets Industry Opportunities and Challenges Table 4. Memantine Hydrochloride Tablets Industry Restraints Table 5. Global Memantine Hydrochloride Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Memantine Hydrochloride Tablets Revenue Share by Company (2021-2026) Table 7. Global Memantine Hydrochloride Tablets Sales Volume by Company (kg) & (2021-2026) Table 8. Global Memantine Hydrochloride Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Memantine Hydrochloride Tablets Average Price (USD/g) of Company (2021-2026) Table 10. Global Memantine Hydrochloride Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Memantine Hydrochloride Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Memantine Hydrochloride Tablets Company, Product Type & Application Table 13. Global Memantine Hydrochloride Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Memantine Hydrochloride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Immediate-Release Tablets Table 18. Significant Companies of Extended-Release Tablets Table 19. Global Memantine Hydrochloride Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Memantine Hydrochloride Tablets Sales Volume by Type (2021-2026) & (kg) Table 21. Global Memantine Hydrochloride Tablets Sales Volume by Type (2027-2032) & (kg) Table 22. Global Memantine Hydrochloride Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Memantine Hydrochloride Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Memantine Hydrochloride Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Memantine Hydrochloride Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Memantine Hydrochloride Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Memantine Hydrochloride Tablets Sales Value Share by Type (2021-2026) Table 28. Global Memantine Hydrochloride Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Hospital Pharmacy Table 31. Significant Companies of Online Pharmacy Table 32. Global Memantine Hydrochloride Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Memantine Hydrochloride Tablets Sales Volume by Application (2021-2026) & (kg) Table 34. Global Memantine Hydrochloride Tablets Sales Volume by Application (2027-2032) & (kg) Table 35. Global Memantine Hydrochloride Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Memantine Hydrochloride Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Memantine Hydrochloride Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Memantine Hydrochloride Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Memantine Hydrochloride Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Memantine Hydrochloride Tablets Sales Value Share by Application (2021-2026) Table 41. Global Memantine Hydrochloride Tablets Sales Value Share by Application (2027-2032) Table 42. Global Memantine Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Memantine Hydrochloride Tablets Sales by Region (2021-2026) & (kg) Table 44. Global Memantine Hydrochloride Tablets Sales Market Share by Region (2021-2026) Table 45. Global Memantine Hydrochloride Tablets Sales by Region (2027-2032) & (kg) Table 46. Global Memantine Hydrochloride Tablets Sales Market Share by Region (2027-2032) Table 47. Global Memantine Hydrochloride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Memantine Hydrochloride Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Memantine Hydrochloride Tablets Sales Value Share by Region (2021-2026) Table 50. Global Memantine Hydrochloride Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Memantine Hydrochloride Tablets Sales Value Share by Region (2027-2032) Table 52. Global Memantine Hydrochloride Tablets Market Average Price (USD/g) by Region (2021-2026) Table 53. Global Memantine Hydrochloride Tablets Market Average Price (USD/g) by Region (2027-2032) Table 54. Global Memantine Hydrochloride Tablets Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 55. Global Memantine Hydrochloride Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Memantine Hydrochloride Tablets Sales by Country (2021-2026) & (kg) Table 57. Global Memantine Hydrochloride Tablets Sales Market Share by Country (2021-2026) Table 58. Global Memantine Hydrochloride Tablets Sales by Country (2027-2032) & (kg) Table 59. Global Memantine Hydrochloride Tablets Sales Market Share by Country (2027-2032) Table 60. Global Memantine Hydrochloride Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Memantine Hydrochloride Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Memantine Hydrochloride Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Memantine Hydrochloride Tablets Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceuticals USA Company Information Table 65. Teva Pharmaceuticals USA Business Overview Table 66. Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 67. Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Product Portfolio Table 68. Teva Pharmaceuticals USA Recent Development Table 69. Sun Pharma Company Information Table 70. Sun Pharma Business Overview Table 71. Sun Pharma Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 72. Sun Pharma Memantine Hydrochloride Tablets Product Portfolio Table 73. Sun Pharma Recent Development Table 74. United Laboratories Company Information Table 75. United Laboratories Business Overview Table 76. United Laboratories Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 77. United Laboratories Memantine Hydrochloride Tablets Product Portfolio Table 78. United Laboratories Recent Development Table 79. Upsher-Smith Company Information Table 80. Upsher-Smith Business Overview Table 81. Upsher-Smith Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 82. Upsher-Smith Memantine Hydrochloride Tablets Product Portfolio Table 83. Upsher-Smith Recent Development Table 84. Taj Pharma India Limited Company Information Table 85. Taj Pharma India Limited Business Overview Table 86. Taj Pharma India Limited Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 87. Taj Pharma India Limited Memantine Hydrochloride Tablets Product Portfolio Table 88. Taj Pharma India Limited Recent Development Table 89. Sharon Bio-medicine Limited Company Information Table 90. Sharon Bio-medicine Limited Business Overview Table 91. Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 92. Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Product Portfolio Table 93. Sharon Bio-medicine Limited Recent Development Table 94. Psycogen Captab Company Information Table 95. Psycogen Captab Business Overview Table 96. Psycogen Captab Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 97. Psycogen Captab Memantine Hydrochloride Tablets Product Portfolio Table 98. Psycogen Captab Recent Development Table 99. Kabir Lifesciences Company Information Table 100. Kabir Lifesciences Business Overview Table 101. Kabir Lifesciences Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 102. Kabir Lifesciences Memantine Hydrochloride Tablets Product Portfolio Table 103. Kabir Lifesciences Recent Development Table 104. Consern Pharma Limited Company Information Table 105. Consern Pharma Limited Business Overview Table 106. Consern Pharma Limited Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 107. Consern Pharma Limited Memantine Hydrochloride Tablets Product Portfolio Table 108. Consern Pharma Limited Recent Development Table 109. Aripolis Biotech Pvt. Ltd. Company Information Table 110. Aripolis Biotech Pvt. Ltd. Business Overview Table 111. Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 112. Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio Table 113. Aripolis Biotech Pvt. Ltd. Recent Development Table 114. Ajanta Pharma Ltd. Company Information Table 115. Ajanta Pharma Ltd. Business Overview Table 116. Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 117. Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Product Portfolio Table 118. Ajanta Pharma Ltd. Recent Development Table 119. Actiza Pharmaceutical Pvt. Ltd. Company Information Table 120. Actiza Pharmaceutical Pvt. Ltd. Business Overview Table 121. Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 122. Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio Table 123. Actiza Pharmaceutical Pvt. Ltd. Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Memantine Hydrochloride Tablets Distributors List Table 127. Memantine Hydrochloride Tablets Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Memantine Hydrochloride Tablets Product Image Figure 2. Global Memantine Hydrochloride Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Memantine Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Memantine Hydrochloride Tablets Sales (2021-2032) & (kg) Figure 5. Global Memantine Hydrochloride Tablets Sales Average Price (USD/g) & (2021-2032) Figure 6. Global Memantine Hydrochloride Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Immediate-Release Tablets Image Figure 10. Extended-Release Tablets Image Figure 11. Global Memantine Hydrochloride Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Memantine Hydrochloride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Memantine Hydrochloride Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Memantine Hydrochloride Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Memantine Hydrochloride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Memantine Hydrochloride Tablets Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Hospital Pharmacy Image Figure 19. Online Pharmacy Image Figure 20. Global Memantine Hydrochloride Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Memantine Hydrochloride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Memantine Hydrochloride Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Memantine Hydrochloride Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Memantine Hydrochloride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Memantine Hydrochloride Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Memantine Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 27. Global Memantine Hydrochloride Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Memantine Hydrochloride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Memantine Hydrochloride Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Memantine Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Memantine Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Memantine Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Memantine Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Memantine Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Memantine Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Memantine Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Memantine Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Memantine Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Memantine Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Memantine Hydrochloride Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Memantine Hydrochloride Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate-Release Tablets
  • Extended-Release Tablets
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Teva Pharmaceuticals USA
  • Sun Pharma
  • United Laboratories
  • Upsher-Smith
  • Taj Pharma India Limited
  • Sharon Bio-medicine Limited
  • Psycogen Captab
  • Kabir Lifesciences
  • Consern Pharma Limited
  • Aripolis Biotech Pvt. Ltd.
  • Ajanta Pharma Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Memantine Hydrochloride Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Memantine Hydrochloride Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Memantine Hydrochloride Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Memantine Hydrochloride Tablets Market Dynamics
  1. 2.1 Memantine Hydrochloride Tablets Industry Trends
  2. 2.2 Memantine Hydrochloride Tablets Industry Drivers
  3. 2.3 Memantine Hydrochloride Tablets Industry Opportunities and Challenges
  4. 2.4 Memantine Hydrochloride Tablets Industry Restraints
3 Memantine Hydrochloride Tablets Market by Company
  1. 3.1 Global Memantine Hydrochloride Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Memantine Hydrochloride Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Memantine Hydrochloride Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Memantine Hydrochloride Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Memantine Hydrochloride Tablets Company Ranking (2024-2026)
  6. 3.6 Global Memantine Hydrochloride Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Memantine Hydrochloride Tablets Company Product Type and Application
  8. 3.8 Global Memantine Hydrochloride Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Memantine Hydrochloride Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Memantine Hydrochloride Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Memantine Hydrochloride Tablets Market by Type
  1. 4.1 Memantine Hydrochloride Tablets Type Introduction
  2. 4.1.1 Immediate-Release Tablets
  3. 4.1.2 Extended-Release Tablets
  4. 4.2 Global Memantine Hydrochloride Tablets Sales Volume by Type
  5. 4.2.1 Global Memantine Hydrochloride Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Memantine Hydrochloride Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Memantine Hydrochloride Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Memantine Hydrochloride Tablets Sales Value by Type
  9. 4.3.1 Global Memantine Hydrochloride Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Memantine Hydrochloride Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Memantine Hydrochloride Tablets Sales Value Share by Type (2021-2032)
5 Memantine Hydrochloride Tablets Market by Application
  1. 5.1 Memantine Hydrochloride Tablets Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Memantine Hydrochloride Tablets Sales Volume by Application
  6. 5.2.1 Global Memantine Hydrochloride Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Memantine Hydrochloride Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Memantine Hydrochloride Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Memantine Hydrochloride Tablets Sales Value by Application
  10. 5.3.1 Global Memantine Hydrochloride Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Memantine Hydrochloride Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Memantine Hydrochloride Tablets Sales Value Share by Application (2021-2032)
6 Memantine Hydrochloride Tablets Regional Sales and Value Analysis
  1. 6.1 Global Memantine Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Memantine Hydrochloride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Memantine Hydrochloride Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Memantine Hydrochloride Tablets Sales by Region (2027-2032)
  5. 6.3 Global Memantine Hydrochloride Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Memantine Hydrochloride Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Memantine Hydrochloride Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Memantine Hydrochloride Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Memantine Hydrochloride Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Memantine Hydrochloride Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Memantine Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Memantine Hydrochloride Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Memantine Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Memantine Hydrochloride Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Memantine Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Memantine Hydrochloride Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Memantine Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Memantine Hydrochloride Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Memantine Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
7 Memantine Hydrochloride Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Memantine Hydrochloride Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Memantine Hydrochloride Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Memantine Hydrochloride Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Memantine Hydrochloride Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Memantine Hydrochloride Tablets Sales by Country (2027-2032)
  6. 7.4 Global Memantine Hydrochloride Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Memantine Hydrochloride Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Memantine Hydrochloride Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Memantine Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Memantine Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Memantine Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals USA
  2. 8.1.1 Teva Pharmaceuticals USA Company Information
  3. 8.1.2 Teva Pharmaceuticals USA Business Overview
  4. 8.1.3 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals USA Recent Developments
  7. 8.2 Sun Pharma
  8. 8.2.1 Sun Pharma Company Information
  9. 8.2.2 Sun Pharma Business Overview
  10. 8.2.3 Sun Pharma Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharma Memantine Hydrochloride Tablets Product Portfolio
  12. 8.2.5 Sun Pharma Recent Developments
  13. 8.3 United Laboratories
  14. 8.3.1 United Laboratories Company Information
  15. 8.3.2 United Laboratories Business Overview
  16. 8.3.3 United Laboratories Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 United Laboratories Memantine Hydrochloride Tablets Product Portfolio
  18. 8.3.5 United Laboratories Recent Developments
  19. 8.4 Upsher-Smith
  20. 8.4.1 Upsher-Smith Company Information
  21. 8.4.2 Upsher-Smith Business Overview
  22. 8.4.3 Upsher-Smith Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Upsher-Smith Memantine Hydrochloride Tablets Product Portfolio
  24. 8.4.5 Upsher-Smith Recent Developments
  25. 8.5 Taj Pharma India Limited
  26. 8.5.1 Taj Pharma India Limited Company Information
  27. 8.5.2 Taj Pharma India Limited Business Overview
  28. 8.5.3 Taj Pharma India Limited Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taj Pharma India Limited Memantine Hydrochloride Tablets Product Portfolio
  30. 8.5.5 Taj Pharma India Limited Recent Developments
  31. 8.6 Sharon Bio-medicine Limited
  32. 8.6.1 Sharon Bio-medicine Limited Company Information
  33. 8.6.2 Sharon Bio-medicine Limited Business Overview
  34. 8.6.3 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Product Portfolio
  36. 8.6.5 Sharon Bio-medicine Limited Recent Developments
  37. 8.7 Psycogen Captab
  38. 8.7.1 Psycogen Captab Company Information
  39. 8.7.2 Psycogen Captab Business Overview
  40. 8.7.3 Psycogen Captab Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Psycogen Captab Memantine Hydrochloride Tablets Product Portfolio
  42. 8.7.5 Psycogen Captab Recent Developments
  43. 8.8 Kabir Lifesciences
  44. 8.8.1 Kabir Lifesciences Company Information
  45. 8.8.2 Kabir Lifesciences Business Overview
  46. 8.8.3 Kabir Lifesciences Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kabir Lifesciences Memantine Hydrochloride Tablets Product Portfolio
  48. 8.8.5 Kabir Lifesciences Recent Developments
  49. 8.9 Consern Pharma Limited
  50. 8.9.1 Consern Pharma Limited Company Information
  51. 8.9.2 Consern Pharma Limited Business Overview
  52. 8.9.3 Consern Pharma Limited Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Consern Pharma Limited Memantine Hydrochloride Tablets Product Portfolio
  54. 8.9.5 Consern Pharma Limited Recent Developments
  55. 8.10 Aripolis Biotech Pvt. Ltd.
  56. 8.10.1 Aripolis Biotech Pvt. Ltd. Company Information
  57. 8.10.2 Aripolis Biotech Pvt. Ltd. Business Overview
  58. 8.10.3 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
  60. 8.10.5 Aripolis Biotech Pvt. Ltd. Recent Developments
  61. 8.11 Ajanta Pharma Ltd.
  62. 8.11.1 Ajanta Pharma Ltd. Company Information
  63. 8.11.2 Ajanta Pharma Ltd. Business Overview
  64. 8.11.3 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Product Portfolio
  66. 8.11.5 Ajanta Pharma Ltd. Recent Developments
  67. 8.12 Actiza Pharmaceutical Pvt. Ltd.
  68. 8.12.1 Actiza Pharmaceutical Pvt. Ltd. Company Information
  69. 8.12.2 Actiza Pharmaceutical Pvt. Ltd. Business Overview
  70. 8.12.3 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
  72. 8.12.5 Actiza Pharmaceutical Pvt. Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Memantine Hydrochloride Tablets Value Chain Analysis
  2. 9.1.1 Memantine Hydrochloride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Memantine Hydrochloride Tablets Sales Mode & Process
  6. 9.2 Memantine Hydrochloride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Memantine Hydrochloride Tablets Distributors
  9. 9.2.3 Memantine Hydrochloride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research